SCHEMBL4929926

SCHEMBL4929926

FC(F)(F)Oc1ccc(-n2c(Cl)nc3cc(Cl)c(Cl)cc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
ADRB3 P13945 1/20 0.40
TSPO P30536 1/20 0.40
GRM5 P41594 1/20 0.40
KCNH2 Q12809 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
GPR35 Q9HC97 1/20 0.40
HCAR1 Q9BXC0 1/20 0.37
TRPV4 Q9HBA0 3/20 0.36
NPBWR1 P48145 2/20 0.36
MCHR1 Q99705 2/20 0.36
TDP2 O95551 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
CTSC P53634 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931175 0.85 DHODH (0.44) L3MBTL1POLBMAPTMAPK1RECQL
SCHEMBL4927330 0.83 DCTPP1 (0.36) MAPTDCTPP1
SCHEMBL4933492 0.81 DCTPP1 (0.53) MAPTDCTPP1
SCHEMBL4931085 0.78 CACNA2D1 (0.43) MAPTMCHR1DCTPP1
SCHEMBL2283234 0.77 IDH1 (0.49) L3MBTL1POLB
SCHEMBL4929730 0.77 DRD2 (0.42)
SCHEMBL19137944 0.76 HSD11B1 (0.42) L3MBTL1MAPTMAPK1RECQLTDP2
SCHEMBL4924682 0.76 CACNA2D1 (0.46) L3MBTL1MAPTMAPK1DCTPP1PDE2A
SCHEMBL4922605 0.74 TRPC5 (0.45) L3MBTL1POLBMAPTMCHR1GCGR
SCHEMBL4928564 0.74 TRPV1 (0.38) L3MBTL1POLBMAPTPDE2ADHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 L3MBTL1 4264/4885POLB 4843/4885MAPT 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.